TVARDI THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase Decrease In Operating Lease Liability of -$56.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$28.00K.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$28.00K.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$28.00K.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$26.00K.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$103.00K.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$93.00K.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$1.92M.
- TVARDI THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$1.75M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$56.00K 10-Q · filed 2026-08-14 | -$84.00K derived: sum of 3 quarters · filed 2026-08-14 | -$110.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | -$28.00K 10-Q · filed 2026-05-08 | -$56.00K derived: sum of 2 quarters · filed 2026-05-08 | -$82.00K derived: sum of 3 quarters · filed 2026-05-08 | -$107.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$54.00K derived: sum of 2 quarters · filed 2026-03-31 | -$79.00K derived: sum of 3 quarters · filed 2026-08-14 | -$103.00K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$51.00K derived: sum of 2 quarters · filed 2026-08-14 | -$75.00K 10-Q · filed 2025-11-13 | -$99.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$49.00K 10-Q · filed 2026-08-14 | -$73.00K derived: sum of 3 quarters · filed 2026-08-14 | -$97.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | -$24.00K 10-Q · filed 2026-05-08 | -$48.00K derived: sum of 2 quarters · filed 2026-05-08 | -$72.00K derived: sum of 3 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$48.00K derived: sum of 2 quarters · filed 2026-03-31 | -$93.00K 10-K · filed 2026-03-31 | -$4.36M 10-K · filed 2025-03-11 | ||
| 2024-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$69.00K 10-Q · filed 2025-11-13 | -$4.36M 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | -$45.00K 10-Q · filed 2025-08-14 | |||||
| 2023-12-31 | -$640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$982.00K derived: sum of 2 quarters · filed 2025-03-11 | -$1.46M derived: sum of 3 quarters · filed 2025-03-11 | -$1.92M 10-K · filed 2025-03-11 | ||
| 2023-09-30 | -$342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$816.00K derived: sum of 2 quarters · filed 2024-11-14 | -$1.28M 10-Q · filed 2024-11-14 | -$1.73M derived: sum of 4 quarters · filed 2025-03-11 | ||
| 2023-06-30 | -$474.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$936.00K 10-Q · filed 2024-08-14 | -$1.39M derived: sum of 3 quarters · filed 2025-03-11 | -$1.84M derived: sum of 4 quarters · filed 2025-03-11 | ||
| 2023-03-31 | -$462.00K 10-Q · filed 2024-05-13 | -$917.00K derived: sum of 2 quarters · filed 2025-03-11 | -$1.36M derived: sum of 3 quarters · filed 2025-03-11 | -$1.79M derived: sum of 4 quarters · filed 2025-03-11 | ||
| 2022-12-31 | -$455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$900.00K derived: sum of 2 quarters · filed 2025-03-11 | -$1.33M derived: sum of 3 quarters · filed 2025-03-11 | -$1.75M 10-K · filed 2025-03-11 | ||
| 2022-09-30 | -$445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$877.00K derived: sum of 2 quarters · filed 2023-11-13 | -$1.30M 10-Q · filed 2023-11-13 | -$1.72M derived: sum of 4 quarters · filed 2024-03-06 | ||
| 2022-06-30 | -$432.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$855.00K 10-Q · filed 2023-08-07 | -$1.27M derived: sum of 3 quarters · filed 2024-03-06 | -$1.68M derived: sum of 4 quarters · filed 2024-03-06 | ||
| 2022-03-31 | -$423.00K 10-Q · filed 2023-05-15 | -$839.00K derived: sum of 2 quarters · filed 2024-03-06 | -$1.25M derived: sum of 3 quarters · filed 2024-03-06 | -$1.64M derived: sum of 4 quarters · filed 2024-03-06 | ||
| 2021-12-31 | -$416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$822.00K derived: sum of 2 quarters · filed 2024-03-06 | -$1.22M derived: sum of 3 quarters · filed 2024-03-06 | -$1.60M 10-K · filed 2024-03-06 | ||
| 2021-09-30 | -$406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$800.00K derived: sum of 2 quarters · filed 2022-11-07 | -$1.19M 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | -$394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$780.00K 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | -$386.00K 10-Q · filed 2022-05-09 | |||||
| 2020-12-31 | -$1.09M 10-K · filed 2023-03-06 | |||||
| 2019-12-31 | -$879.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |